These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25824763)

  • 1. Effects of metformin on cell kinetic parameters of MCF-7 breast cancer cells in vitro.
    Topcul M; Cetin I
    Asian Pac J Cancer Prev; 2015; 16(6):2351-4. PubMed ID: 25824763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lily polysaccharide 1 enhances the effect of metformin on proliferation and apoptosis of human breast carcinoma cells].
    Hou J; Li F; Li X; Mei Q; Mi M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):780-3. PubMed ID: 27371846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formononetin and metformin act synergistically to inhibit growth of MCF-7 breast cancer cells in vitro.
    Xin M; Wang Y; Ren Q; Guo Y
    Biomed Pharmacother; 2019 Jan; 109():2084-2089. PubMed ID: 30551465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective Cellular Transport of
    Markowicz-Piasecka M; Komeil I; Huttunen J; Sikora J; Huttunen KM
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do MCF7 cells cope with metformin treatment under energetic stress in low glucose conditions?
    Dogan Turacli I; Umudum H; Pampal A; Candar T; Kavasoglu L; Sari Y
    Mol Biol Rep; 2018 Jun; 45(3):195-201. PubMed ID: 29397517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro cytotoxic effect of tyrosine kinase inhibitor sunitinib malate alone and in combination with hyperthermia on breast adenocarcinoma MCF-7 cells.
    Topcul MR; Cetin I
    J BUON; 2016; 21(3):556-63. PubMed ID: 27569072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the Sensitivity of MCF-7 and MCF-7/DX Breast Cancer Cells to Cytostatic in the Presence of Metformin.
    Płonka-Czerw J; Żyrek L; Latocha M
    Molecules; 2024 Jul; 29(15):. PubMed ID: 39124936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of antidiabetic drug metformin on human breast carcinoma cells with different estrogen receptor expressing in vitro].
    Wang Y; Zhang MX; Duan XY; Zhou SN; Ermek T; Wang YN; Cai H; Wang JS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar; 27(3):253-6. PubMed ID: 21419041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose Deprivation Enhances the Antiproliferative Effects of Oral Hypoglycemic Biguanides in Different Molecular Subtypes of Breast Cancer: an in Vitro Study.
    Bardaweel SK; Alsalamat HA; Aleidi SM; Bashatwah RM
    Acta Pharm; 2018 Dec; 68(4):517-524. PubMed ID: 31259708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin is synthetically lethal with glucose withdrawal in cancer cells.
    Menendez JA; Oliveras-Ferraros C; Cufí S; Corominas-Faja B; Joven J; Martin-Castillo B; Vazquez-Martin A
    Cell Cycle; 2012 Aug; 11(15):2782-92. PubMed ID: 22809961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin effects on malignant cells and healthy PBMC; the influence of metformin on the phenotype of breast cancer cells.
    Damjanović A; Matić IZ; Ðorđić M; Ðurović MN; Nikolić S; Roki K; Milovanović Z; Antić-Stanković J; Džodić R; Damjanović S; Kanjer K; Abu Rabi Z; Juranić Z
    Pathol Oncol Res; 2015 Jul; 21(3):605-12. PubMed ID: 25351941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin and erlotinib synergize to inhibit basal breast cancer.
    Lau YK; Du X; Rayannavar V; Hopkins B; Shaw J; Bessler E; Thomas T; Pires MM; Keniry M; Parsons RE; Cremers S; Szabolcs M; Maurer MA
    Oncotarget; 2014 Nov; 5(21):10503-17. PubMed ID: 25361177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative activity of monastrol in human adenocarcinoma (MCF-7) and non-tumor (HB4a) breast cells.
    Marques LA; Semprebon SC; Niwa AM; D'Epiro GF; Sartori D; de Fátima Â; Ribeiro LR; Mantovani MS
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1279-1288. PubMed ID: 27592117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions.
    Silvestri A; Palumbo F; Rasi I; Posca D; Pavlidou T; Paoluzi S; Castagnoli L; Cesareni G
    PLoS One; 2015; 10(8):e0136250. PubMed ID: 26291325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD).
    Sharma P; Kumar S
    Cell Oncol (Dordr); 2018 Dec; 41(6):637-650. PubMed ID: 30088260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin and metformin exhibit antitumor activity in murine breast cancer.
    Zhao M; Wang Y; Du C; Liu Y; Zhang N; Luo F
    Oncol Rep; 2018 Mar; 39(3):1414-1422. PubMed ID: 29328467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-27a-mediated antiproliferative effects of metformin on the breast cancer cell line MCF-7.
    Zhao W; Zhang X; Liu J; Sun B; Tang H; Zhang H
    Oncol Rep; 2016 Dec; 36(6):3691-3699. PubMed ID: 27779715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular interactions between metformin and D-limonene inhibit proliferation and promote apoptosis in breast and liver cancer cells.
    Salim EI; Alabasy MM; Nashar EME; Al-Zahrani NS; Alzahrani MA; Guo Z; Beltagy DM; Shahen M
    BMC Complement Med Ther; 2024 May; 24(1):185. PubMed ID: 38711049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin inhibits proliferation and promotes apoptosis of HER2 positive breast cancer cells by downregulating HSP90.
    Chen TW; Liang YN; Feng D; Tao LY; Qi K; Zhang HY; Wang HX; Lin QS; Kong H
    J BUON; 2013; 18(1):51-6. PubMed ID: 23613388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin and propranolol combination prevents cancer progression and metastasis in different breast cancer models.
    Rico M; Baglioni M; Bondarenko M; Laluce NC; Rozados V; André N; Carré M; Scharovsky OG; Menacho Márquez M
    Oncotarget; 2017 Jan; 8(2):2874-2889. PubMed ID: 27926515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.